
Metsera
(NASDAQ) MTSR
Metsera Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$314.41M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MTSR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Metsera
Industry
Biotechnology
Sector
Health CareEmployees
132
CEO
Christopher Whitten Bernard, MBA
Website
metsera.comHeadquarters
New York City, NY 10007, US
MTSR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-80%
Return on Capital
-74%
Return on Assets
-55%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$224.83M
EBITDA
$218.23M
Operating Cash Flow
$99.79M
Capital Expenditure
$43.00K
Free Cash Flow
$99.83M
Cash & ST Invst.
$352.45M
Total Debt
$9.80M
Metsera Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
93
N/A
Net Income
$116.23M
-6.0%
EBITDA
$116.21M
-5.7%
Quarterly Fundamentals
Net Cash
$445.62M
+145.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$64.00K
N/A
Short Term Debt
$2.77M
-54.0%
Return on Assets
-55.39%
N/A
Return on Invested Capital
-73.51%
N/A
Free Cash Flow
$81.72M
-188.8%
Operating Cash Flow
$81.72M
-188.8%
